DMYD B — Diamyd Medical AB Share News
0.000.00%
Last trade - 00:00- SEK141.62m
- -SEK6.19m
- SEK0.13m
Brief: Diamyd Medical Gets Positive Feedback From FDA On Diamyd
Brief: Diamyd Medical With Second FDA Fast Track Designation For Diamyd For Prevention Of Type 1 Diabetes
Brief: Diamyd Medical Q3 Loss SEK 40.1 Mln
Brief: Diamyd Medical Net Loss Widens To SEK 29.3 Mln
Brief: The Board In Diamyd Medical Have Resolved On A Rights Issue Of About SEK 114 MLN
Brief: Diamyd Medical Q1 Net Loss Narrows to SEK 32.8 Mln
Brief: Diamyd Medical's Precision Medicine Patent Granted In South Korea
Brief: Diamyd Medical Partners With Diaunion
Brief: Diamyd Says May Offer Advantages In Delaying Type 1 Diabetes Onset
Brief: Diamyd Medical Updates On Booster Trial With Diamyd®
Brief: Diamyd Medical Q4 Operating Income Up At SEK 11.2 Mln
Brief: Anders Essen-Möller Appointed As New Chairman Of The Board Of Diamyd Medical
Brief: Board Of Directors In Diamyd Medical Resolves On A Rights Issue Of Approximately SEK 243 Mln
Brief: Diamyd Trial In Lada Published In Scientific Journal
Brief: Diamyd Medical Says Trading In Subscription Rights Halted
Brief: Diamyd Medical Resolves On Rights Issue Of SEK 163 Million
Brief: Diamyd Medical's Remygen® Trial Results Get Timeline Revision
Brief: Diamyd Medical Q2 Net Loss Widens To SEK 25 Mln
Brief: Diamyd Medical Partners With JDRF